iForumRx
  • Home
  • Resources
    • Resources
      • Advanced Training and Certifications
      • Antimicrobial Stewardship
      • Collaborative Practice
      • Contraception
      • COVID-19
    • Resources
      • Educator Resources
      • Evidence Based Medicine Tutorials
      • Evidence Based Practice Resources
      • Gender Affirming Care
      • Health and Medication Literacy
    • Resources
      • Immunizations
      • Medication Therapy Management (MTM)
      • Opioid Safety and Overdose Prevention
      • Patient Centered Medical Home (PCMH)
    • Resources
      • Pharmacist’s Patient Care Process
      • Point-of-Care Testing (POCT)
      • Tobacco Cessation
      • Transitions of Care
  • Trials/Guidelines
    • Trials & Guidelines
      • Asthma
      • Chronic Kidney Disease
      • Chronic obstructive pulmonary disease (COPD)
      • Diabetes Mellitus
      • Dyslipidemia
    • Trials & Guidelines
      • Heart Failure
      • Hepatitis C
      • Hypertension
      • Mental Health
      • Neurology
    • Trials & Guidelines
      • Obesity and Weight Management
      • Stroke Prevention
      • Substance Use Disorders
      • Women’s Health
  • Commentaries
  • Top Ten Things
  • Donate
  • Login or JOIN!

Select Page

Dan Gillis

Dan Gillis
Dan Gillis
This user account status is Approved
About About
Posts Posts
Comments Comments
not a game changert pt 2The point that we could do more to further reduce risk in patients that we…
On All For One and FOURIER For All!
not a game changer pt 1While giving us assurance that we are not just treating the numbers with this class…
On All For One and FOURIER For All!
Re- Post-hoc Power?Great response. I find that one of the biggest gaps in student (and sometimes peer) comprehension of drug…
On Top Ten Pitfalls to Avoid When Evaluating the Primary Literature
"The compelling evidence from"The compelling evidence from the EMPA-REG OUTCOME study ...should make empagliflozin the preferred second-line agent from the…
On The Heart of the Matter – Is EMPA-REG a Game Changer for Diabetes Management?

Polls


Case: 76-yr old male s/p CABG 10 yr ago; hx of CAD, STEMI, PAD and Afib. Currently taking ASA 81mg and Clopidogrel 75mg daily. What's the best approach to prevent CVD events?

View Results

Loading ... Loading ...
  • Polls Archive

You may also like

No related posts.

About

iForumRx.org is a web-based community of practice designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence.

Learn More

  • About Us
  • Terms of Use
  • Privacy Notice
  • Commentary Archives
  • News Archives

Contact Us

iForumRx.org
Division of Pharmacy Professional Development
University of Mississippi School of Pharmacy
2500 North State Street, N 217
Jackson, Mississippi 39216
iforumrx@gmail.com

Contribute

  • Contribute to iForum Rx
  • Contributing Content
  • Contributing a Commentary
  • Contributing Other Content Types